Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis
Nicole Ehrhardt, Michael E. Doche, Shuang Chen, et al.
Human Molecular Genetics (2017) Vol. 26, Iss. 14, pp. 2719-2731
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

FinnGen provides genetic insights from a well-phenotyped isolated population
Mitja Kurki, Juha Karjalainen, Priit Palta, et al.
Nature (2023) Vol. 613, Iss. 7944, pp. 508-518
Open Access | Times Cited: 2257
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1155
FinnGen: Unique genetic insights from combining isolated population and national health register data
Mitja Kurki, Juha Karjalainen, Priit Palta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 349
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
Yanlan Fang, Hong Chen, Chunlin Wang, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 27, pp. 2974-2983
Open Access | Times Cited: 325
Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping
Zhipeng Liu, Yang Zhang, Sarah E. Graham, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 263-276
Open Access | Times Cited: 193
VLDL Biogenesis and Secretion: It Takes a Village
Willemien van Zwol, Bart van de Sluis, Henry N. Ginsberg, et al.
Circulation Research (2024) Vol. 134, Iss. 2, pp. 226-244
Open Access | Times Cited: 22
Non-alcoholic fatty liver disease in lean individuals
Somaya Albhaisi, Abhijit Chowdhury, Arun J. Sanyal
JHEP Reports (2019) Vol. 1, Iss. 4, pp. 329-341
Open Access | Times Cited: 142
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1638-1638
Open Access | Times Cited: 114
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, et al.
Hepatology (2020) Vol. 72, Iss. 1, pp. 330-346
Open Access | Times Cited: 108
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids
Sebastian Prill, Andrea Caddeo, Guido Baselli, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 97
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
Fei Luo, Federico Oldoni, Avash Das
Hepatology Communications (2021) Vol. 6, Iss. 3, pp. 448-460
Open Access | Times Cited: 91
Liver‐Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer
Elizabeth P. Newberry, Zoe Hall, Yan Xie, et al.
Hepatology (2021) Vol. 74, Iss. 3, pp. 1203-1219
Open Access | Times Cited: 90
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications
Rossella Palma, Annamaria Pronio, Mario Romeo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3649-3649
Open Access | Times Cited: 50
Insulin Regulation of Hepatic Lipid Homeostasis
Kahealani Uehara, Dominic Santoleri, Anna E. Garcia Whitlock, et al.
Comprehensive physiology (2023), pp. 4785-4809
Open Access | Times Cited: 29
PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
X. Charlie Dong
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 64
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population
Daniel Ferraz de Campos Mazo, Fernanda de Mello Malta, José Tadeu Stefano, et al.
Annals of Hepatology (2019) Vol. 18, Iss. 3, pp. 466-471
Open Access | Times Cited: 56
Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver
Mingfeng Xia, Preethi Chandrasekaran, Shunxing Rong, et al.
Journal of Lipid Research (2020) Vol. 62, pp. 100031-100031
Open Access | Times Cited: 54
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
Jan Borén, Martin Adiels, Elias Björnson, et al.
JCI Insight (2020) Vol. 5, Iss. 24
Open Access | Times Cited: 54
Genetics Is of the Essence to Face NAFLD
Marica Meroni, Miriam Longo, Giada Tria, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1359-1359
Open Access | Times Cited: 51
Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
Kahealani Uehara, Jaimarie Sostre‐Colón, Matthew Gavin, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 13, Iss. 6, pp. 1625-1647
Open Access | Times Cited: 29
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism
Jing Liu, Henry N. Ginsberg, Gissette Reyes‐Soffer
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 157-161
Open Access | Times Cited: 8
Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease
Botao Li, Ming Sun, LI Yun-feng, et al.
PLoS Genetics (2020) Vol. 16, Iss. 8, pp. e1008955-e1008955
Open Access | Times Cited: 47
Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 40
Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a
Lei Yu, Joanne A. Hoogerland, Vincent W. Bloks, et al.
Hepatology (2020) Vol. 72, Iss. 5, pp. 1638-1653
Open Access | Times Cited: 33
TM6SF2: A novel target for plasma lipid regulation
Tingting Li, Tao‐Hua Li, Juan Peng, et al.
Atherosclerosis (2017) Vol. 268, pp. 170-176
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top